Navigation Links
PMC Questions Methodology of OIG Report on Power Wheelchair Acquisition Costs
Date:9/8/2009

WASHINGTON, Sept. 8 /PRNewswire/ -- Using flawed methodology and incomplete data, the Department of Health and Human Services (HHS), Office of the Inspector General (OIG) released a report, entitled Power Wheelchairs in the Medicare Program: Supplier Acquisition Costs and Services (OEI-04-07-00400) examining acquisition pricing by providers for a sample of standard and complex rehabilitation power wheelchairs available to Medicare beneficiaries. If readers incorrectly draw conclusions that low acquisition costs equates to high profit margins, then the PMC questions the completeness of the study and its usefulness to policymakers. To obtain a more accurate and complete measure of power wheelchair pricing, the PMC insists that the OIG conduct a thorough analysis that examines both acquisition costs and mandatory provider outlays necessary to partner with the Medicare program.

In their report, the OIG admittedly failed to calculate costs of the services provided as well as overhead expenses, including salaries, fuel, transportation, rents, inventories, home assessment and beneficiary assistance in billing Medicare. Additionally, many providers have aggressively adopted the Centers for Medicare and Medicaid Service's (CMS's) initiatives to fight fraud by earning accreditation and acquiring surety bonds prior to the mandated deadline, which has significantly raised overhead and administrative costs. As PMC Director Eric Sokol explains, "Increased Medicare standards and documentation confusion has raised the cost to providers of partnering with the Medicare program. As provider liabilities increase, the acquisition cost of equipment is a shrinking component of the provider's cost structure."

Moreover, Medicare reimbursement for power wheelchairs has decreased dramatically since 2006. Both CMS and Congress have cut Medicare reimbursement for standard power chairs by over 37% in that time period. Additional cuts are anticipated when CMS implements competitive bidding for certain durable medical equipment, including standard power wheelchairs, in January 2011. For this reason, the PMC agrees with CMS that the agency should not initiate unilateral authority, through inherent reasonableness, to cut the Medicare fee schedule further for standard power wheelchairs until such a time as the competitive bidding program has been correctly implemented.

Access to quality power wheelchairs saves the Medicare program resources by making beneficiaries safe in their environment, allowing them to avoid costly hospitalizations and procedures. Further downward pressure on pricing will force some providers out of the Medicare market, jeopardizing access to this life enhancing medical equipment to eligible beneficiaries.

A complete copy of the OIG report can be found at: http://oig.hhs.gov/oei/reports/oei-04-07-00400.pdf.

The Power Mobility Coalition (PMC) is a nationwide association of manufacturers and suppliers of motorized wheelchairs and power operated vehicles based in Washington, D.C.


'/>"/>
SOURCE The Power Mobility Coalition
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise
2. Study Questions Dead-End Cancer Clinical Trials
3. 6 Years Later, 9/11 Health Questions Linger
4. RFID Implant Cancer Questions Concern Patients
5. Study Questions Genetic Screening for Treatable Diseases
6. New study questions the validity of publishing hospital mortality rates
7. Study Questions Flu Shots Value for Older People
8. Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology
9. Study questions assumptions about human sensitivity to biological motion
10. Childrens Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection
11. New study questions disparities in vascular surgery among Hispanics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... How to Walk with God #TruthwithGrace”: a devotional journal chronicling the writer’s path ... to Learning How to Walk with God #TruthwithGrace” is the creation of published ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of ... college Bible teacher residing in North Carolina with his wife, Anna Marie. He and ... with six grandchildren. David is also the author of “Shadow and Substance.” , “Love, ...
(Date:3/24/2017)... ... , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: a ... to the fullest, as God intended. “The Adventures of Joey, The Dog Who Barks ... pursuing her passion for writing, especially about truth and human behavior. , Published by ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... A recent ... for entry into teacher preparation programs. The NCTQ report suggests, based on a review ... requirements would significantly improve teacher quality in the U.S. It argues that this higher ...
(Date:3/23/2017)... Alexandria, Virginia (PRWEB) , ... March 23, 2017 ... ... quality public health services to their communities, 16 more public health departments have ... This week’s decisions bring another 4.5 million people into the expanding network of ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition ... report to their offering. ... Pain Management in the U.S.: ... physical pain, emphasizing consumer survey analysis, including trends over time. ... who have selected illnesses/conditions strongly associated with physical pain and ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The IPF pipeline is very strong with a total of 97 drug ... Biogen and Sanofi are involved in the development of the IPF therapeutics. ... in Phase III stage, 15 are in Phase II stage, 12 are ...
Breaking Medicine Technology: